Stroke Trial, Recruiting NCT06731673 Sponsor: University of Aarhus Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06731673
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have given their informed consent to participate
  • VTE group: People who have been diagnosed with a deep vein thrombosis (a blood clot in a vein) confirmed by ultrasound, OR a pulmonary embolism (a blood clot in the lungs) confirmed by a CT scan
  • Heart attack group: People who have shown a specific heart rhythm pattern (ST-segment elevation) on an ECG, AND have a blocked artery identified on a coronary angiogram
  • Stroke group: People who have had a stroke confirmed by an MRI scan, AND have an irregular heart rhythm called atrial fibrillation detected by heart monitoring, AND whose stroke occurred in a specific area of the brain associated with that condition
  • Healthy group: People who are in good health with no known conditions

Who may not be able to join:

  • People under 18 years of age
  • People who have not given informed consent
  • People with known blood disorders
  • People with an active blood cancer
  • People with severely reduced kidney function (as measured by a specific blood test called eGFR being below 15) or those on dialysis
  • VTE group: People whose pulmonary embolism was found by accident during a CT scan done for a different reason, and who do not also have a blood clot in a vein
  • Heart attack group: People whose heart condition was caused by a tear in the artery wall, or by a stress-related heart condition called Takotsubo cardiomyopathy
  • Stroke group: People whose stroke appears to have been caused by disease in a large blood vessel, rather than an irregular heart rhythm
  • Healthy group: People with any known current or ongoing illness, or anyone who has previously had a blood clot, heart attack, stroke, or similar condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +45 20 65 27 32

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 December 2024
Est. completion
31 August 2027

Where this trial is recruiting

🇩🇰 Denmark 🇩🇪 Germany

Primary endpoints

Platelet levels of heat shock protein 47 (HSP47) in patients with thrombosis compared to healthy controls

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov